Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Hamada Tsutsumi, Susumu ^a   Iio, Etsuko ^a   Watanabe, Tsunamasa ^a   Murakami, Shuko ^a   Isogawa, Masanori ^a   Iijima, Sayuki ^a   Inoue, Takako ^a   Matsunami, Kayoko ^a   Tajiri, Kazuto ^b   Ozawa, Tatsuhiko ^b   Kishi, Hiroyuki ^b   Muraguchi, Atsushi ^b   Joh, Takashi ^a   Tanaka, Yasuhito ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEPATITIS B VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HB0116; MONOCLONAL ANTIBODY HB0478; UNCLASSIFIED DRUG; HEPATITIS B ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; KOREA; MOUSE; NONHUMAN; VIRUS NEUTRALIZATION; ANIMAL; CELL LINE; IMMUNOLOGY; IMMUNOPRECIPITATION; PATHOGENICITY; VIROLOGY;

HEPATITIS B VIRUS; MUS; NON-A, NON-B HEPATITIS VIRUS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS; IMMUNOPRECIPITATION; MICE;

EID: 84923343144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118062     Document Type: Article

References (30)

1. Miyakawa Y, Mizokami M (2003) Classifying hepatitis B virus genotypes. Intervirology 46:329-338. PMID: 14688448
2. Kim BK, Revill PA, Ahn SH (2011) HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther (Lond) 16:1169-1186. doi: 10.3851/IMP1982 PMID: 22155900
3. Kurbanov F, Tanaka Y, Mizokami M (2010) Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res 40:14-30. doi: 10.1111/j.1872-034X.2009.00601.x PMID: 20156297
4. Yan H, Zhong G, Xu G, He W, Jing Z, et al. (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1:e00049. doi: 10.7554/eLife.00049 PMID: 23150796
5. Shokrgozar MA, Shokri F (2002) Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine. Vaccine 20:2215-2220. PMID: 12009275
6. Zanetti AR, Van Damme P, Shouval D (2008) The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266-6273. doi: 10.1016/j.vaccine.2008.09.056 PMID: 18848855
7. Cassidy A, Mossman S, Olivieri A, De Ridder M, Leroux-Roels G (2011) Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity. Expert Rev Vaccines 10:1709-1715. doi: 10.1586/erv. 11.151 PMID: 22085174
8. Ogata N (2009) [Comparison of antibody responses to hepatitis B surface antigen among four recipient groups of hepatitis B vaccines that have been approved in Japan: evaluation using passive hemagglutination assay and chemiluminescent immunoassay]. Rinsho Byori 57:954-960. PMID: 19928491
9. Avazova D, Kurbanov F, Tanaka Y, Sugiyama M, Radchenko I, et al. (2008) Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan. J Med Virol 80:217-224. PMID: 18098129
10. Matsuura K, Tanaka Y, Hige S, Yamada G, Murawaki Y, et al. (2009) Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 47:1476-1483. doi: 10.1128/JCM.02081-08 PMID: 19297602
11. Jin A, Ozawa T, Tajiri K, Obata T, Kondo S, et al. (2009) A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med 15:1088-1092. doi: 10.1038/nm.1966 PMID: 19684583
12. Tajiri K, Kishi H, Tokimitsu Y, Kondo S, Ozawa T, et al. (2007) Cell-microarray analysis of antigenspecific B-cells: single cell analysis of antigen receptor expression and specificity. Cytometry A 71:961-967. PMID: 17910063
13. Tokimitsu Y, Kishi H, Kondo S, Honda R, Tajiri K, et al. (2007) Single lymphocyte analysis with a microwell array chip. Cytometry A 71:1003-1010. PMID: 17972305
14. Tajiri K, Ozawa T, Jin A, Tokimitsu Y, Minemura M, et al. (2010) Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. ANTIVIRAL RESEARCH 87:40-49. doi: 10.1016/j.antiviral.2010.04.006 PMID: 20412816
15. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, et al. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7:927-933. PMID: 11479625
16. Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, et al. (2009) Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinasetype plasminogen activator mouse with human hepatocytes. Gastroenterology 136:652-62-e653. doi: 10.1053/j.gastro.2008.10.048 PMID: 19041311
17. Allweiss L, Volz T, Lutgehetmann M, Giersch K, Bornscheuer T, et al. (2014) Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferonalpha administration. J Hepatol 60:500-507. doi: 10.1016/j.jhep. 2013.10.021 PMID: 24398036
18. Cooreman MP, Leroux-Roels G, Paulij WP (2001) Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8:237-247. PMID: 11385295
19. Wu C, Deng W, Deng L, Cao L, Qin B, et al. (2012) Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol 86:4658-4669. doi: 10.1128/JVI.06353-11 PMID: 22301154
20. Komatsu H, Inui A, Sogo T, Konishi Y, Tateno A, et al. (2012) Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. BMC Res Notes 5:22. doi: 10.1186/1756-0500-5-22 PMID: 22233650
21. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, et al. (2002) Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 99:15655-15660. PMID: 12432097
22. Cerec V, Glaise D, Garnier D, Morosan S, Turlin B, et al. (2007) Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45:957-967. PMID: 17393521
23. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, et al. (1999) Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37:2899-2903. PMID: 10449472
24. Fujiwara K, Tanaka Y, Paulon E, Orito E, Sugiyama M, et al. (2005) Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E. J Virol 79:14404-14410. PMID: 16254374
25. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ (2006) Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44:694-702. PMID: 16941694
26. Qiu X, Schroeder P, Bridon D (1996) Identification and characterization of a C (K/R) TC motif as a common epitope present in all subtypes of hepatitis B surface antigen. J Immunol 156:3350-3356. PMID: 8617960
27. Iwarson S, Tabor E, Thomas HC, Goodall A, Waters J, et al. (1985) Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol 16:89-96. PMID: 2413167
28. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, et al. (2011) Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 364:236-247. doi: 10.1056/NEJMoa1007644 PMID: 21247314
29. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH (1997) Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176:427-430. PMID: 9237708
30. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F (1986) A synthetic peptide vaccine involving the product of the pre-S (2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83:9174-9178. PMID: 3466181